Acquisition - December 2, 2025
AddLife acquires Pharmacold and Opitek International
Pharmacold is a Danish specialist in refrigeration technology and service for the pharmaceutical and healthcare sectors and Opitek International is a manufacturer specializing in patient positioning.
Acquisition - November 17, 2025
Lundbeck submits proposal to acquire Irish Avadel
Lundbeck confirms that it has submitted a non-binding proposal to acquire Avadel.
Acquisition - November 7, 2025
The takeover offer of Bavarian Nordic is withdrawn and will not be completed
Earlier this autumn the company announced a takeover offer to acquire all of the issued and outstanding shares in Bavarian Nordic by Innosera, a company controlled by Nordic Capital Fund XI and funds managed and advised by Permira Beteiligungsberatung. The offeror has now informed Bavarian Nordic that, as the minimum acceptance condition has not been satisfied, […]
Acquisition - November 3, 2025
Thermo Fisher Scientific to acquire Clario
Thermo Fisher Scientific has announced a definitive agreement to acquire Clario Holdings, a provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for USD 8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance.
Acquisition - October 31, 2025
Novo Nordisk submits proposal to acquire Metsera
The acquisition of Metsera, including its early and development-stage incretin and non-incretin analogue peptide programmes, would provide Novo Nordisk the opportunity to maximize the potential of Metsera’s complementary portfolio and capabilities, it states.
Acquisition - October 27, 2025
Novartis to acquire RNA therapeutics company Avidity Biosciences
Novartis has entered into an agreement to acquire Avidity Biosciences, a San Diego-based, biopharmaceutical company focused on a new class of therapeutics enabling RNA delivery to muscle.